Drug Profile
Research programme: calcineurin inhibitors - Isomerase Therapeutics
Alternative Names: nPT-CLNLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Biotica Technology
- Class Lactones; Macrolides
- Mechanism of Action Calcineurin inhibitors; Cytokine inhibitors; Immunosuppressants; T cell activation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Asthma
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in United Kingdom (Inhalation)
- 02 Oct 2009 Preclinical trials in Asthma in United Kingdom (Inhalation)